Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALYPSO: CAELYX and Carboplatin vs. Paclitaxel and Carboplatin in Epithelial Ovarian Cancer
NCT00538603Phase 3Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jun 2005
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of doxorubicin in epithelial ovarian cancer (EOC), sponsored by King Faisal Specialist Hospital and Research Centre. Started Jun 2005; status: completed.
02
Drugs
doxorubicin
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT00538603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538603.